Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

The challenge for the next generation of feline calicivirus vaccines.

Radford AD, Dawson S, Coyne KP, Porter CJ, Gaskell RM.

Vet Microbiol. 2006 Oct 5;117(1):14-8. Epub 2006 Apr 18. Review.

PMID:
16698199
2.
3.

Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.

Poulet H, Brunet S, Leroy V, Chappuis G.

Vet Microbiol. 2005 Mar 20;106(1-2):17-31. Epub 2005 Jan 21.

PMID:
15737470
4.

Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.

Ohe K, Sakai S, Takahasi T, Sunaga F, Murakami M, Kiuchi A, Fukuyama M, Furuhata K, Hara M, Ishikawa Y, Taneno A.

Vet Res Commun. 2007 May;31(4):497-507.

PMID:
17225086
5.

FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.

Ohe K, Takahashi T, Hara D, Hara M.

Vet Res Commun. 2008 Feb;32(2):145-58. Epub 2007 Sep 25.

PMID:
17899424
7.

Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.

Scott FW, Geissinger CM.

Am J Vet Res. 1999 May;60(5):652-8. Erratum in: Am J Vet Res 1999 Jun;60(6):763.

PMID:
10328440
8.

Feline calicivirus: a need for vaccine modification?

Baulch-Brown C, Love DN, Meanger J.

Aust Vet J. 1997 Mar;75(3):209-13. Review. No abstract available.

PMID:
9088514
9.

Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.

Jas D, Aeberlé C, Lacombe V, Guiot AL, Poulet H.

Vet J. 2009 Oct;182(1):86-93. doi: 10.1016/j.tvjl.2008.05.025. Epub 2008 Aug 9.

PMID:
18694649
10.

Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.

Gore TC, Lakshmanan N, Williams JR, Jirjis FF, Chester ST, Duncan KL, Coyne MJ, Lum MA, Sterner FJ.

Vet Ther. 2006 Fall;7(3):213-22.

PMID:
17039444
11.

[Yearly booster vaccine against feline calicivirus (FCV) for high risk cases].

[No authors listed]

Tijdschr Diergeneeskd. 2007 May 15;132(10):402. Dutch. No abstract available.

PMID:
17578234
12.

Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.

Rong S, Lowery D, Floyd-Hawkins K, King V.

Virus Res. 2014 Aug 8;188:60-7. doi: 10.1016/j.virusres.2014.03.007. Epub 2014 Mar 29.

PMID:
24685673
13.

Feline calicivirus.

Radford AD, Coyne KP, Dawson S, Porter CJ, Gaskell RM.

Vet Res. 2007 Mar-Apr;38(2):319-35. Epub 2007 Feb 13. Review.

14.

Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.

Lappin MR, Andrews J, Simpson D, Jensen WA.

J Am Vet Med Assoc. 2002 Jan 1;220(1):38-42.

PMID:
12680445
15.

Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.

Poulet H, Jas D, Lemeter C, Coupier C, Brunet S.

Vaccine. 2008 Jul 4;26(29-30):3647-54. doi: 10.1016/j.vaccine.2008.04.082. Epub 2008 May 21.

PMID:
18541348
16.

Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.

Porter CJ, Radford AD, Gaskell RM, Ryvar R, Coyne KP, Pinchbeck GL, Dawson S.

J Feline Med Surg. 2008 Feb;10(1):32-40. Epub 2007 Aug 27.

PMID:
17720588
17.

Endemic infection of a cat colony with a feline calicivirus closely related to an isolate used in live attenuated vaccines.

Radford AD, Sommerville L, Ryvar R, Cox MB, Johnson DR, Dawson S, Gaskell RM.

Vaccine. 2001 Aug 14;19(31):4358-62.

PMID:
11483259
18.

Feline calicivirus strains isolated in Italy.

Rinaldo D, Foti M, Bottari T, Fisichella V, Buonavoglia D.

Pol J Vet Sci. 2008;11(4):359-61.

PMID:
19227135
19.

DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein.

Sommerville LM, Radford AD, Glenn M, Dawson S, Gaskell CJ, Kelly DF, Cripps PJ, Porter CJ, Gaskell RM.

Vaccine. 2002 Mar 15;20(13-14):1787-96.

PMID:
11906766
20.

Supplemental Content

Support Center